“LL-37”的搜索结果，显示 41-50 项，共有 6960 项

1. 外科 - 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44 · Go to page 55 · NextNext Page. 以下为当前的临床试验。 131 研究外科（仅限开放性研究）. 按位置、状态和其他条件筛选 ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

3. 血液科- 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does ...

4. 血液科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and efficacy ...

6. 甲状腺癌 - 医生与科室 - 妙佑医疗国际

   ... 2��00G0G0G0="语言选择器"�_o2帏它ﱯu0l}}nav,�/976nrvG0G01�]_o2帏它ﱯu0l}}fanguageNavigar�5drdV�_e6ln0G0Glanguagenavigar�5d 0G0Glanguagenavigar�5d ct�drrray ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EOC. Patients ...

8. 血液科- 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

10. 外科 - 临床试验- 妙佑医疗国际

    Go to page 22 · Go to page 33 · Go to page 44 · Go to page 55 · NextNext Page. 以下为当前的临床试验。 132 研究外科（仅限开放性研究）. 按位置、状态和其他条件筛选 ...